Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysisJiHoon Kang, Baek‐Yeol Ryoo, Inhwan Hwang et al.|Investigational New Drugs|2018Cited by 148
A Comparative Study of Laparoscopic vs Open Distal Pancreatectomy for Left-Sided Ductal Adenocarcinoma: A Propensity Score-Matched AnalysisSang Hyun Shin, Young Joo Lee, Song Cheol Kim et al.|Journal of the American College of Surgeons|2014Cited by 121
Genetic Alterations of K-ras, p53, c-erbB-2, and DPC4 in Pancreatic Ductal Adenocarcinoma and Their Correlation With Patient SurvivalSang Hyun Shin, Youngjoo Lee, Song Cheol Kim et al.|Pancreas|2013Cited by 105
Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinomaJae‐Lyun Lee, Duck Jong Han, Song Cheol Kim et al.|Surgery|2012Cited by 103
Laparoscopic central pancreatectomy for benign or low-grade malignant lesions in the pancreatic neck and proximal bodyKi Byung Song, Young Joo Lee, Song Cheol Kim et al.|Surgical Endoscopy|2014Cited by 70